New heart stent shows promise in 888-Patient trial

NCT ID NCT06769217

Completed Disease control Sponsor: Frisch Medical Device Private Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug-coated stent called EvroSure in 888 people with blocked heart arteries. The stent releases medicine to keep the artery open and prevent future blockages. Researchers tracked major heart events like heart attacks or the need for repeat procedures at 30 days and 12 months to see if the stent is safe and works well.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERIAL DISEASE (CAD)

Contacts and locations

Show contact details

Locations

Baroda Heart Institute & Research Centre

Vadodara, Gujarat, 390007, India
Grandmed Lubuk Pakam Hospita

Tanjung Morawa, North Sumatra, Indonesia
Hospital (P) Ltd.

Kozhikode, Kerala, 673002, India
Medical College & Hospital

Bangalore, Karnataka, India
Primaya Tangerang

Jakarta, Indonesia